C
IPSC icon

Covestor’s Century Therapeutics IPSC Stock Holding History

Covestor’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed – – 2473
2023
Q4 		$0 Buy
+3
New +$5 ﹤0.01% 2395

Other funds holding IPSC

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Covestor's IPSC Position: Q1 2024 in Review

Covestor sold out of Century Therapeutics (IPSC) in Q1 2024, closing a stake of 3 shares.

Covestor first reported a position in IPSC in Q4 2023 and held it in 1 quarter. The position peaked at $0 in Q4 2023. 67 funds tracked by Wall St. Rank hold IPSC as of Q1 2024.

  • Covestor reported no remaining Century Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Covestor sold 3 Century Therapeutics shares in Q1 2024.
  • Covestor first reported a position in Century Therapeutics in Q4 2023 and held it in 1 quarter.
  • Covestor's Century Therapeutics position peaked at $0 in Q4 2023.
  • 67 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2024.

Based on Covestor's 13F filing for Q1 2024, filed 10 May 2024.